A multivariate approach for assessing severity of acute graft-versus-host disease in bone marrow transplantation

被引:0
|
作者
Parrish, RS
Hazlett', LJ
Bridges, KD
Henslee-Downey, PJ
机构
[1] Ctr Canc, Div Biometry & Res Comp, Columbia, SC 29203 USA
[2] Univ S Carolina, Sch Med, Dept Med, Ctr Canc Treatment & Res,Palmetto Richland Mem Ho, Columbia, SC 29208 USA
[3] Univ S Carolina, Sch Med, Ctr Canc Treatment & Res, Dept Pediat,Palmetto Richland mem Hosp, Columbia, SC USA
[4] Univ S Carolina, Sch Med, Palmetto Richland Mem Hosp, Div Transplantat Med,Ctr Canc Treatment & Res, Columbia, SC USA
关键词
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Patients undergoing bone marrow transplantation are at high risk of developing acute graft-versus-host disease (GVHD) which is a primary limiting factor for this procedure inasmuch as it is responsible for high morbidity rates and is associated with poor survival outcome. To provide improved treatment assessment and better interpretation of clinical outcomes, we need a precise and objective assessment of GVHD, Severity of GVHD is commonly assessed using an imprecise categorical grading system that incorporates skin, gut and liver grades, as well as subjective assessment of clinical performance. These organ grades are based on arbitrary cutpoints of skin rash, diarrhoea volume and bilirubin level. The International Bone Marrow Transplant Registry proposed an alternative grading system based on different combinations of organ involvement and provided estimates of relative risk of treatment failure. On the basis of that work, we developed an empirical mathematical model that quantifies GVHD severity, and that uses continuous, rather than categorical, daily measurements for each organ system. We use model-predicted values as an index of severity for any combination of values. The proposed index allows a more precise comparison of GVHD profiles across different treatment protocols and also permits more refined analyses to address relationships between GVHD and clinical outcomes. Copyright (C) 1999 John Wiley & Sons, Ltd.
引用
收藏
页码:423 / 440
页数:18
相关论文
共 50 条
  • [21] THALIDOMIDE FOR GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION
    SAURAT, JH
    CAMENZIND, M
    HELG, C
    CHAPUIS, B
    LANCET, 1988, 1 (8581): : 359 - 359
  • [22] CYCLOSPORINE AND GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION
    SCHMIDT, H
    EINSELE, H
    JASCHONEK, K
    DOPFER, R
    EHNINGER, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (24): : 1607 - 1607
  • [23] GRAFT-VERSUS-HOST DISEASE IN EXPERIMENTAL ALLOGENEIC BONE-MARROW TRANSPLANTATION
    KORNGOLD, R
    SPRENT, J
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1991, 197 (01): : 12 - 18
  • [24] Oral eicosapentaenoic acid for acute colonic graft-versus-host disease after bone marrow transplantation
    Takatsuka, H
    Takemoto, Y
    Yamada, S
    Wakae, T
    Mori, A
    Okada, M
    Iwata, N
    Okamoto, T
    Kanamaru, A
    Kakishita, E
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 2002, 28 (04) : 121 - 125
  • [25] A metalloproteinase inhibitor prevents acute graft-versus-host disease in mice after bone marrow transplantation
    K Hattori
    T Hirano
    C Ushiyama
    H Miyajima
    N Yamakawa
    S Ikeda
    K Yoshino
    M Tateno
    K Oshimi
    N Kayagaki
    H Yagita
    K Okumura
    Bone Marrow Transplantation, 1999, 23 : 1283 - 1289
  • [26] Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation
    McNeel, D
    Rubio, MT
    Damaj, G
    Emile, JF
    Belanger, C
    Varet, B
    Brousse, N
    Hermine, O
    Buzyn, A
    TRANSPLANTATION, 2002, 74 (12) : 1797 - 1800
  • [27] Serum TNFα levels in patients with acute graft-versus-host disease after bone marrow transplantation
    Huang, XJ
    Wan, J
    Lu, DP
    LEUKEMIA, 2001, 15 (07) : 1089 - 1091
  • [29] Fludarabine monophosphate reduces the incidence and severity of graft-versus-host disease in a murine model of bone marrow transplantation
    Or, R
    Weiss, L
    Teiman, S
    Polliack, A
    BLOOD, 1997, 90 (01) : 471 - 471
  • [30] Unexplained effusions: Association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease
    Pretnar, J
    Cernelc, P
    Mlakar, U
    Fortuna, M
    BONE MARROW TRANSPLANTATION, 1996, 18 (04) : 826 - 826